Plasmodium parasites are the etiological agents of malaria, a disease responsible for over
half a million deaths annually. Successful completion of the parasite's life cycle in the …

A more sensitive surveillance tool is needed to identify Plasmodium vivax infections for
treatment and to accelerate malaria elimination efforts. To address this challenge, our …

After several decades in development, two malaria vaccines based on the same antigen and
with very similar constructs and adjuvants, RTS, S/AS01 (RTS, S) and R21/Matrix-M (R21) …

Malaria remains a significant threat to global health, responsible for more than 200 million
clinical cases and almost half a million deaths each year. 1 Leading malaria vaccine …

Ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and
COVID-19 disease severity is influenced by immunity acquired by natural exposure and/or …

Analysis of the capability of IgG antibodies and receptors with their relationships to food
tolerance and autoimmune disorders Page 1 International Journal of Natural Medicine and …

Background Whole parasite vaccination is an efficacious strategy to induce sterile immunity
and to prevent malaria transmission. Understanding the mechanism and response of …

Malaria vaccines targeting the circumsporozoite protein (CSP) of the P. falciparum parasite
have been overall relatively promising. RTS, S is a pre-erythrocytic recombinant protein …

Background: RTS, S/AS01 has been recommended by WHO for widespread implementation
in medium to high malaria transmission settings. Previous analyses have noted lower …

Malaria remains a leading cause of childhood mortality, thereby highlighting the need for an
effective vaccine. R21 is a virus-like particle-based (VLP-based) vaccine displaying the …